TETRAPHASE PHARMACEUTICALS I

CUSIP: 88165N105 Class: COMMON STOCK

ROYCE & ASSOCIATES LP's Holding History (CIK: 0000906304)

Note: Option positions (PUT/CALL) are excluded.

Q2 2019
Shares 527,900 Value ($000) $254 Avg Close — Range —
Q1 2019
Shares 527,900 Value ($000) $707 Avg Close — Range —
Q4 2018
Shares 476,900 Value ($000) $539 Avg Close — Range —
Q3 2018
Shares 476,900 Value ($000) $1,316 Avg Close — Range —
Q2 2018
Shares 155,800 Value ($000) $556 Avg Close — Range —